Compounds > diclofenac

diclofenac and minocycline

diclofenac has been researched along with minocycline in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (6.25)	18.2507
2000's	4 (25.00)	29.6817
2010's	8 (50.00)	24.3611
2020's	3 (18.75)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Farrell, GC	1
Sadowski, T; Steinmeyer, J	1
Badolo, L; Dalgaard, L; Dubois, J; Hansen, SH; Otto, M	1
Abagyan, R; Atayee, R; Cohen, IV; Makunts, T	1
Arias-Moliz, MT; Baca, P; Ferrer-Luque, CM; Rodríguez-Archilla, A; Ruiz-Linares, M; Solana, C	1
Andrade, RJ; Björnsson, ES; Lucena, MI; Medina-Caliz, I	1
Legkova, KS; Topchy, TB; Volchkova, EA	1

Reviews

2 review(s) available for diclofenac and minocycline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Drug-induced hepatic injury. Journal of gastroenterology and hepatology, 1997, Volume: 12, Issue:9-10 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Azathioprine; Chemical and Drug Induced Liver Injury; Diclofenac; Drugs, Chinese Herbal; Floxacillin; Humans; Immunosuppressive Agents; Liver Diseases; Minocycline; Penicillins	1997

Other Studies

14 other study(ies) available for diclofenac and minocycline

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013
Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. The Journal of rheumatology, 2001, Volume: 28, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cattle; Cell Survival; Cells, Cultured; Chondrocytes; Diclofenac; Interleukin-1; Joints; Meloxicam; Minocycline; Nitric Oxide Synthase; Thiazines; Thiazoles	2001
Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity. Cell biology and toxicology, 2008, Volume: 24, Issue:1 Topics: Animals; Biological Assay; Biotransformation; Cell Death; Cell Line; Cyclophosphamide; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Glucose-6-Phosphate; Humans; Liver; Minocycline; NADP; Rats	2008
Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications. Scientific reports, 2017, 05-03, Volume: 7, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Data Mining; Depression; Diclofenac; Drug Repositioning; Humans; Information Storage and Retrieval; Ketamine; Minocycline; Pain; United States; United States Food and Drug Administration	2017
Antibiofilm Activity of Diclofenac and Antibiotic Solutions in Endodontic Therapy. Journal of endodontics, 2021, Volume: 47, Issue:7 Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Dentin; Diclofenac; Enterococcus faecalis; Microscopy, Confocal; Minocycline	2021
Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports. Hepatology communications, 2022, Volume: 6, Issue:8 Topics: Adalimumab; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Infliximab; Interferons; Methyldopa; Methylprednisolone; Minocycline; Nitrofurantoin	2022
[COVID-19 as a trigger of autoimmune hepatitis. Case report]. Terapevticheskii arkhiv, 2022, Feb-15, Volume: 94, Issue:2 Topics: Adult; Antiviral Agents; COVID-19; Diclofenac; Etanercept; Female; Hepatitis, Autoimmune; Humans; Infliximab; Male; Methyldopa; Minocycline	2022